Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements longevity clinical trial healthy aging peptides
Approach: Data as art, with a conceptual twist. Palette: bold color field (D). Subject: a single glass syringe lying on a saturated mustard-yellow acrylic surface, shot from a low three-quarter angle with a shallow depth of field. Behind it, a long arc of thin copper wire rises in a gentle curve from a small spike to a broad plateau and then slowly tapers, echoing a hormone curve stretched across days. Small, evenly spaced glass beads sit along the wire, each slightly larger toward the plateau. One bead glows soft electric green. Lighting: hard single softbox from the upper left, creating crisp, short shadows in warm umber on the yellow. Specular highlights on the glass and copper. Mood: precise, patient, and quietly analytical, with a slow-release rhythm. No text or markings anywhere.
Peptides

Uji Manungso CJC‑1295: Apa Data GH lan IGF‑I Sing Bener Nggambarake?

Helix Ward · · 4 min read
#clinical trial #peptides #wada #cjc 1295 #ghrh #growth hormone #igf 1

Uji Manungso CJC‑1295: Apa Data GH lan IGF‑I Sing Bener Nggambarake?

CJC‑1295 kerep muncul ing forum bio‑hacking, iklan klinik, lan buletin anti‑doping. Nanging sing luwih sithik dielingi yaiku studi manungso sing dadi dhasar obrolan iki. Dipublikasikaké ing taun 2006 ing The Journal of Clinical Endocrinology & Metabolism, uji sing ditindakake déning Teichman lan kanca‑kanca dadi referensi utama kanggo analog hormon pertumbuhan (GHRH) jangka panjang iki. Ayo padha ngerti apa sing dituduhaké lan apa sing ora dituduhaké.

Apa Sing Diparingi CJC‑1295

GHRH alami ngirim sinyal menyang pituitari supaya nglairaké hormon pertumbuhan (GH), sing banjur ndorong ati lan jaringan liyané ngasilaké insulin‑like growth factor I (IGF‑I). Hormon iki kuat, nanging aweté cendhak. Kaya sing dakkandhakake penulis, panggunaan terapeutik GHRH diwatesi amarga durasi aksi sing cekak. Molekul sing ilang saka awak mung sajrone sawetara menit ora gampang dadi obat praktis.

CJC‑1295 dirancang dadi analog GHRH sing awet. Uji iki pengin mangertèni telung bab utama: kepiye awak ngolah obat iki (farmakokinetik), apa sing ditindake marang GH lan IGF‑I (farmakodinamik), lan apa aman kanggo wong diwasa sing sehat.

Cara Desain Uji

Uji iki kalebu loro percobaan acak, double‑blind, kontrol plasebo, kanthi dosis mundhak sing lumaku 28 lan 49 dina, lan dilakokaké ing loro situs penelitian. Pesertané wong diwasa sehat umur 21 nganti 61 taun.

  • Studi siji: Peserta nampa CJC‑1295 utawa plasebo minangka suntikan subkutan tunggal kanthi salah siji saka patang tingkat dosis sing mundhak.
  • Studi loro: Peserta nampa loro utawa telu dosis CJC‑1295 utawa plasebo, diwènèhaké saben minggu utawa saben rong minggu.

Outcome utama yaiku konsentrasi puncak lan area ngisor kurva (AUC) kanggo GH lan IGF‑I, bebarengan karo paramèter farmakokinetik standar kanggo obat iki.

Apa Angka‑Angkane Nampilaké

Hasilé nggumunaké kanggo suntikan tunggal:

  • Hormon pertumbuhan: Konsentrasi plasma GH rata‑rata mundhak antara 2 nganti 10 kaping, gumantung dosis, lan kenaikan iki tetep paling ora 6 dina.
  • IGF‑I: Konsentrasi plasma IGF‑I rata‑rata mundhak 1,5‑ nganti 3‑kaping, lan tetep dhuwur nganti 9‑11 dina.
  • Setengah umur: Setengah umur CJC‑1295 diprakirakaké 5,8 nganti 8,1 dina. Kabeh peptida suntik biasané ilang saka awak ing menit nganti jam, dadi iki pancen dawa.
  • Dosis bolak‑bolak: Sawisé sawetara dosis, tingkat IGF‑I rata‑rata tetep di atas baseline nganti 28 dina, nuduhaké efek kumulatif.
  • Keamanan: Ora ana reaksi samping serius sing dilaporaké. Obat iki digambaraké aman lan cukup ditampa, utamané ing dosis 30 utawa 60 µg/kg.

Hubungan dosis‑respons iki migunani amarga nuduhaké yèn respon hormonal selaras karo jumlah obat sing diwènèhaké.

DAC vs. “Mod GRF 1‑29”: Nglurusi Kebingungan Umum

Kebingungan bab CJC‑1295 asale saka loro produk sing nganggo jeneng sing padha.

Molekul ing studi iki yaiku versi awet sing biasané disebut CJC‑1295 karo DAC, ing ngendi DAC iku drug affinity complex. Modifikasi kimia iki nggawe peptida tetep awet nganti pirang‑pirang dina, lan dadi sebab setengah umur meh seminggu sing diamati.

Produk liyane biasané didol minangka “CJC‑1295 tanpa DAC”. Secara teknik, iku peptida sing beda, luwih akurat disebut modified GRF (1‑29) utawa “mod GRF 1‑29”. Iku fragmen GHRH sing dimodifikasi tanpa komponen awet lan diprediksi tumindak luwih cekak. Studi iki ora nyoba produk iku. Data saka studi iki ora bisa dipindhah menyang mod GRF 1‑29, lan nyatakake perkara iki penting.

Yèn ana sing nyebut “studi CJC‑1295” kanggo ndhukung produk sing tindakané cekak, iku salah nggabungaké loro molekul.

Apa Sing Ora Dituduhake Uji Iki

Iki bagéan sing asring ilang ing diskusi online. Uji iki mung minangka studi farmakokinetik, farmakodinamik, lan keamanan ing sukarelawan sehat. Outcome‑e mung ukuran hormon lan prilaku obat. Ringkesané ora nyebutake pengukuran:

  • Massa utawa kekuatan otot
  • Lemes utawa komposisi awak
  • Prestasi atletik utawa fisik
  • Turu, pemulihan, kepadatan balung, utawa fungsi kognitif
  • Keamanan jangka panjang

Munggahake GH lan IGF‑I mung biomarker. Iku ora padha karo bukti manfaat klinis. Apa IGF‑I sing luwih dhuwur bakal nerjemahaké dadi perbaikan sing berarti ing wong sehat, iku pitakonan sing ora dijawab déning uji iki. Uji iki uga cekak, mung 28 lan 49 dina, dadi ora nyritakake apa sing kedadeyan sajrone sasi utawa taun paparan. Kenaikan IGF‑I sing awet dadi perhatian peneliti, amarga poros GH/IGF‑I nyambung rapet karo pertumbuhan, metabolisme, lan biologi umur. Ringkesané ora nanggepi pitakonan jangka panjang iku, lan ora patut dianggep rampung.

Kasunyatan Regulator

CJC‑1295 durung tau disetujui dadi obat. Penulis nyimpulaké yèn data ndhukung potensi kegunaan terapeutik, nanging potensi ora padha karo persetujuan. Saiki produk iki mung ana minangka peptida riset, lan barang sing didol kanthi jeneng iki variatif kualitas, identitas, lan labelé. Uga dilarang ing olahraga: World Anti‑Doping Agency (WADA) ndhaptar obat iki minangka faktor pelepas hormon pertumbuhan, mula atlet kompetitif kena sanksi.

Kesimpulan

Uji 2006 iku studi fase awal sing kuat. Iku nuduhaké yèn suntikan subkutan tunggal saka analog GHRH awet bisa nambah GH nganti kira‑kira seminggu lan IGF‑I luwih saka seminggu, yèn dosis bolak‑bolak nambah efek kuwi, lan tolerabilitas jangka pendek ing wong sehat katon apik. Nanging iki uga studi sing sempit: ora ana data komposisi awak, ora ana endpoint kinerja, ora ana tindak lanjut jangka panjang, lan ora nglibataké mod GRF 1‑29 sing asring dijual nganggo label sing padha. Sapa wae sing nimbang klaim babagan CJC‑1295 kudu nganggep makalah iki minangka bukti aktivitas hormonal lan keamanan jangka pendek, ora minangka bukti manfaat sing asring dipromosikaké pemasaran.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Macro science: an extreme close-up of GHK-Cu copper peptide crystals, deep blue-violet needle-like crystals with faceted edges, shot at a low three-quarter angle with a shallow depth of field so the nearest crystals are razor sharp and the rest dissolve into soft blur. The crystals sit on a smooth, glossy tomato-red backdrop that fills the frame, creating a bold color field. Lighting is a single large softbox from the upper left, giving crisp specular highlights on the crystal faces and a soft, warm-red bounce in the shadows. One tiny thread of electric green light refracts through a single crystal edge as a subtle accent. Mood: striking, precise, curious, scientific without feeling sterile. Photorealistic microscopy-meets-studio look, no text, no labels, no people.
peptides

Peptida Tembaga GHK‑Cu Bisa Nyetel Gen Ing Balik Perbaikan Kulit

BY NOVA CHEN ·

GHK‑Cu, peptida tembaga sing asring ditemokaké ing sérum, ora mung kanggo nambah kelembapan kulit. Review 2018 nuduhaké yèn data ekspresi gen anyar bisa nerangaké kepiye molekul cilik iki nyambung karo pambentukan kolagen, perbaikan jaringan, kontrol inflamasi, lan malah perbaikan DNA. Kéné ringkesan temuan lan cathetan praktis panggunaan topikal sing bisa dipriksa sadurungé percoyo marang hype.
Approach: Lab in action. Palette: D, bold color field. A gloved hand holds a clear petri dish at a slight low angle, close and slightly above eye level, against a saturated tomato-red backdrop. Inside the dish, a thin, translucent layer of pale pink culture medium holds a faint, lacy web of fibroblast cells, with a few small clusters just visible. Hard, clean studio light from the upper left throws a crisp curved shadow of the dish onto the red surface and picks out bright highlights on the rim and the glove's matte white nitrile. In the soft-focus background, a rack of empty microcentrifuge tubes stands out in cool white. One tiny electric green cap on a single tube adds a small accent. The mood is precise and skeptical: a promising result still confined to the dish.
peptides

Epithalon Aktifaké Telomerase ing Sel — Nanging Ora ing Manungsa

BY HELIX WARD ·

Peptida cilik papat asam amino dilapuraké bisa nguripaké telomerase, enzim sing biasané dipendem ing sel dewasa, lan nambah dawa telomer ing sel manungsa. Iki minangka temuan sing dadi latar mburi hype Epithalon babagan umur dawa. Nanging panaliténé namung ditindakake nganggo fibroblas janin sing ditandur ing cawan, ora nganggo subyek manungsa. Klaim babagan perpanjangan umur mung hipotesis. Ing ngisor iki apa sing bener‑bener dituduhaké déning studi 2003, apa sing ora dielingi, lan cara maca bukti sadurunge tuku apa wae.
Approach: conceptual metaphor. Palette: bold color field. A single AA-style cylindrical battery, shown as a real object with a bare metal cap and a plain unlabeled matte sleeve, stands upright on a glossy surface. It is photographed from a low three-quarter angle against a saturated tomato-red seamless backdrop. The battery is half-filled with a translucent amber liquid that visibly rises inside a clear glass cutaway section. A thin ribbon of electric green light (#00e676) wraps around its base like a charging band. Soft large-softbox light comes from the upper left and produces crisp highlights on the metal and a clean, slightly blurred red reflection beneath it. A second, shorter battery sits out of focus behind, nearly drained and empty, to suggest contrast. The mood is energetic, optimistic and precise, with a tactile product-photography look and shallow depth of field.
supplements

NR + Pterostilbene Nambah NAD+ Kira‑kira 40–90 % ing Uji Manungsa

BY NOVA CHEN ·

Apa kapsul saben dina sing ngandhut nicotinamide riboside lan pterostilbene isa nambah NAD+ ing wong tuwa? Ing uji coba kapisan NRPT (Basis) sing ditindakake ing manungsa, 120 wong umur 60‑80 taun njupuk suplemen iki sajrone wolung minggu. NAD+ ing getih mundhak kira‑kira 40 % kanthi dosis sing disaranake lan 90 % kanthi dosis dobel, lan kenaikan iki tetep stabil nganti pungkasan uji. Ora ana efek samping serius sing dilaporaké.
Approach: conceptual metaphor. Palette: bold color field. A single steel bathroom-style analog tape measure, pulled taut and wrapped around a ripe, glossy yellow-orange pear lying on its side, with the tape's tip locked at the same unmarked point, suggesting a waistline that did not shrink. The pear sits on a saturated magenta seamless backdrop, shot from a low three-quarter angle with a shallow depth of field, the stem sharp and the background softly blurred. Hard but slightly diffused studio key light from upper left casts a crisp, short shadow in deeper magenta on the surface. A tiny electric green sticky dot marks the tape's end, with no numbers or writing visible. Mood: playful, skeptical, deadpan, scientific restraint rather than hype.
longevity

Rapamycin Mingguan Sajerone Taun: Aman, Nanging Apa Lemak Visceral Nggowahi?

BY REX MERIDIAN ·

Saben wong kepengin ngerti apa rapamycin mingguan bisa nyuda lemak visceral lan ningkatake healthspan. Uji coba PEARL maringi jawaban sing bisa ngagetaké. Sawisé 48 minggu ing wong diwasa sing sehat, asil utama babagan lemak visceral ora owah, nanging keamanané padha karo plasebo. Sawetara sinyal sekunder – kaya peningkatan massa lean lan rasa nyeri sing luwih sithik ing wanita sing nampa 10 mg, lan rasa kesejahteraan sing luwih apik ing dosis 5 mg – nuduhaké potensi manfaat. Nanging temuan iki asalé saka subkelompok lan laporan diri, rapamycin sing digunakake digawé khusus, lan durung ana bukti yèn iki nambah umur manungsa. Ing ngisor iki apa sing didhukung data lan apa sing ora.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文